{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-226113","form_type":"8-K","ticker":"LNTH","cik":"0001521036","company_name":"Lantheus Holdings, Inc.","filed_at":"2024-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.359139+00:00","generated_at":"2026-05-31T01:47:27.774861+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lantheus to release SPLASH trial data in Oct 2024 after 75% OS events reached","bullets":["Expects to release Phase 3 SPLASH data in October 2024 for 177Lu-PNT2002 in PSMA-expressing mCRPC.","Release triggered by reaching 75% of protocol-specified target overall survival events.","Trial randomized 412 patients 2:1; 84.6% of control arm crossed over to PNT2002.","Primary endpoint is radiographic progression-free survival; 80% of patients from North America."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-226113","json":"https://secwatch.observer/filing/0001193125-24-226113.json","markdown":"https://secwatch.observer/filing/0001193125-24-226113.md","text":"https://secwatch.observer/filing/0001193125-24-226113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524226113/0001193125-24-226113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1521036/000119312524226113/d868473d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:47:27.774861+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}